Development and cross-validation of sequencing-based assays for genotyping common polymorphisms of the CXCL5 gene

Clinica Chimica Acta

Volumn 370, Issue 1-2, 2006, Pages 72-75

  Zineh, Issam ^a   Welder, Gregory J ^a   Langaee, Taimour Y ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

CXCL5; ENA 78; Genotype; Polymorphism; Pyrosequencing; TaqMan

Indexed keywords

ALPHA CHEMOKINE; EPITHELIAL NEUTROPHIL ACTIVATING PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DNA POLYMORPHISM; EUROPE; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HUMAN; METHODOLOGY; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; POPULATION GENETICS; PRIORITY JOURNAL; UNITED STATES;

ALLELES; BASE SEQUENCE; CHEMOKINES, CXC; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; REPRODUCIBILITY OF RESULTS;

ENA;

EID: 33746101082     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.01.025     Document Type: Article

References (9)

1. Walz A., Burgener R., Car B., Baggiolini M., Kunkel S.L., and Strieter R.M. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med 174 (1991) 1355-1362
2. Nakayama S., Mukae H., Ishii H., Kakugawa T., Sugiyama K., Sakamoto N., et al. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Respir Med 99 (2005) 1145-1151
3. Wislez M., Philippe C., Antoine M., Rabbe N., Moreau J., Bellocq A., et al. Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells. Inflamm Res 53 (2004) 4-12
4. Koch A.E., Volin M.V., Woods JM., Kunkel S.L., Connors M.A., Harlow L.A., et al. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum 44 (2001) 31-40
5. Walz A., Strieter R.M., and Schnyder S. Neutrophil-activating peptide ENA-78. Adv Exp Med Biol 351 (1993) 129-137
6. Walz A., Schmutz P., Mueller C., and Schnyder-Candrian S. Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol 62 (1997) 604-611
7. Zineh I., Luo X., Welder G.J., DeBella A.E., Wessel T.R., Arant C.B., et al. Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors. Pharmacotherapy 26 3 (2006) 333-340
8. Amoli M.M., Larijani B., Thomson W., Ollier W.E., and Gonzalez-Gay M.A. Two polymorphisms in the epithelial cell-derived neutrophil-activating peptide (ENA-78) gene. Dis Markers 21 (2005) 75-77
9. Amoli M.M., Thomson W., Hajeer A.H., Calvino M.C., Garcia-Porrua C., Ollier W.E., et al. Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 29 (2002) 2367-2370